These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 31501220

  • 1. Identifying Patients With Kawasaki Disease Safe for Early Discharge: Development of a Risk Prediction Model at a US Children's Hospital.
    Hester GZ, Watson D, Nickel AJ, Ryan N, Jepson B, Gray J, Bergmann KR.
    Hosp Pediatr; 2019 Oct; 9(10):749-756. PubMed ID: 31501220
    [Abstract] [Full Text] [Related]

  • 2. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 3. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [Abstract] [Full Text] [Related]

  • 4. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
    Clin Drug Investig; 2011 Feb; 31(3):191-9. PubMed ID: 21456105
    [Abstract] [Full Text] [Related]

  • 5. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

  • 6. A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease.
    Qian W, Tang Y, Yan W, Sun L, Lv H.
    Ital J Pediatr; 2018 Mar 09; 44(1):33. PubMed ID: 29523168
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):78. PubMed ID: 31775782
    [Abstract] [Full Text] [Related]

  • 8. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
    Ha KS, Lee J, Lee KC.
    Eur J Pediatr; 2020 Feb 27; 179(2):257-264. PubMed ID: 31713683
    [Abstract] [Full Text] [Related]

  • 9. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
    Huang H, Jiang J, Shi X, Qin J, Dong J, Xu L, Huang C, Liu Y, Zheng Y, Hou M, Shen Q, Zeng B, Qian G, Yang F, Lv H.
    Ann Med; 2022 Dec 27; 54(1):442-453. PubMed ID: 35099338
    [Abstract] [Full Text] [Related]

  • 10. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
    [Abstract] [Full Text] [Related]

  • 11. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.
    Hosp Pediatr; 2014 Jul 18; 4(4):233-8. PubMed ID: 24986993
    [Abstract] [Full Text] [Related]

  • 12. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
    Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, Qian W, Qian G, Qin L, Lv H.
    Eur J Pediatr; 2018 Aug 18; 177(8):1279-1292. PubMed ID: 29948255
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database.
    Moffett BS, Syblik D, Denfield S, Altman C, Tejtel-Sexson K.
    Pediatr Cardiol; 2015 Feb 18; 36(2):374-8. PubMed ID: 25179461
    [Abstract] [Full Text] [Related]

  • 14. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
    Li SY, Ding Y.
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar 15; 25(3):244-249. PubMed ID: 36946157
    [Abstract] [Full Text] [Related]

  • 15. IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease.
    Weng KP, Hsieh KS, Ho TY, Huang SH, Lai CR, Chiu YT, Huang SC, Lin CC, Hwang YT, Ger LP.
    Circ J; 2010 Mar 15; 74(3):544-51. PubMed ID: 20081319
    [Abstract] [Full Text] [Related]

  • 16. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT, Chang CH, Sun LC, Liu HM, Chang HW, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH.
    J Formos Med Assoc; 2016 May 15; 115(5):350-5. PubMed ID: 25910931
    [Abstract] [Full Text] [Related]

  • 17. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
    Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A.
    Circulation; 2006 Jun 06; 113(22):2606-12. PubMed ID: 16735679
    [Abstract] [Full Text] [Related]

  • 18. Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease.
    Bar-Meir M, Kalisky I, Schwartz A, Somekh E, Tasher D, Israeli Kawasaki Group.
    J Pediatric Infect Dis Soc; 2018 Feb 19; 7(1):25-29. PubMed ID: 28062554
    [Abstract] [Full Text] [Related]

  • 19. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S.
    Rheumatol Int; 2019 Aug 19; 39(8):1343-1349. PubMed ID: 31139951
    [Abstract] [Full Text] [Related]

  • 20. Variability in Response to Intravenous Immunoglobulin in the Treatment of Kawasaki Disease.
    Downie ML, Manlhiot C, Latino GA, Collins TH, Chahal N, Yeung RS, McCrindle BW.
    J Pediatr; 2016 Dec 19; 179():124-130.e1. PubMed ID: 27659027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.